Sales up 36% organically, and 26% better than ABGSCe At an inflection point for profitability with high drop-through in '23e Trading 64% bel...
Sales 26% better than ABGSCe with 36% organic growth Order backlog should support high-20s organic growth in '23e Valued at 12x '24e EV/EBIT...
Order intake up 49% organically, but EBIT 29% below ABGSCe Less able to scale as costs increase; we cut '24e EBIT by 21% Trading 37% below p...
Remarkable order intake 35% better than ABGSCe ‘23e EBIT up 8% and ‘24e up 4% Fair value range of SEK 45-95/share Orders up 46% y-o-y, 77%...
Order intake 35% better than ABGSCe Strength in APAC drove 9% sales beat Cons EBIT estimates likely to come up 5% Q2 numbers C-RAD delivere...
Orders 2% better, sales 3% below, EBIT 94% below Lost installations should come back in H2 High growth, attractive position, at large discou...
Omicron softens installations and orders in Q1’22e Sales down 3-2% ’22-24e on FX and supply chain High non-cyclical growth at 54% discount t...
Service standing out in Q2 EBIT beat of 12% Q2 was characterized by a return to normalcy with organic growth of 51%, compared to a quarter s...
